BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25293878)

  • 1. Renal sympathetic denervation in patients with hypertension and chronic kidney disease: does improvement in renal function follow blood pressure control?
    Kiuchi MG; Chen S; Andrea BR; Kiuchi T; Carreira MA; Graciano ML; Lugon JR
    J Clin Hypertens (Greenwich); 2014 Nov; 16(11):794-800. PubMed ID: 25293878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
    Marin F; Fezzi S; Gambaro A; Ederle F; Castaldi G; Widmann M; Gangemi C; Ferrero V; Pesarini G; Pighi M; Ribichini FL
    J Nephrol; 2021 Oct; 34(5):1445-1455. PubMed ID: 33481223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Toennes SW; Ewen S; Ditting T; Veelken R; Ukena C; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number of ablated spots in the course of renal sympathetic denervation in CKD patients with uncontrolled hypertension: EnligHTN vs. Standard irrigated cardiac ablation catheter.
    Kiuchi MG; Chen S; Rodrigues Paz LM; Pürerfellner H
    Hipertens Riesgo Vasc; 2018; 35(2):54-63. PubMed ID: 28784273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term verification of functional and structural renal damage after renal sympathetic denervation.
    Dörr O; Liebetrau C; Möllmann H; Gaede L; Troidl C; Wiebe J; Renker M; Bauer T; Hamm C; Nef H
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1298-303. PubMed ID: 26699846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.
    Desch S; Okon T; Heinemann D; Kulle K; Röhnert K; Sonnabend M; Petzold M; Müller U; Schuler G; Eitel I; Thiele H; Lurz P
    Hypertension; 2015 Jun; 65(6):1202-8. PubMed ID: 25824248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of renal function after renal sympathetic denervation in CKD patients with controlled vs. uncontrolled hypertension.
    Kiuchi MG; Chen S
    Int J Cardiol; 2016 Nov; 223():494-496. PubMed ID: 27544613
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal denervation for resistant hypertension.
    Coppolino G; Pisano A; Rivoli L; Bolignano D
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011499. PubMed ID: 28220472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effect of renal sympathetic denervation on blood pressure in refractory hypertensive patients with chronic kidney disease.
    Kiuchi MG; Chen S; Graciano ML; Carreira MA; Kiuchi T; Andrea BR; Lugon JR
    Int J Cardiol; 2015; 190():29-31. PubMed ID: 25912114
    [No Abstract]   [Full Text] [Related]  

  • 11. Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) Trial.
    Courand PY; Pereira H; Del Giudice C; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Vehier C; Lantelme P; Denolle T; Dourmap C; Halimi JM; Girerd X; Rossignol P; Zannad F; Ormezzano O; Vaisse B; Herpin D; Ribstein J; Bouhanick B; Mourad JJ; Ferrari E; Chatellier G; Sapoval M; Azarine A; Azizi M;
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of renal denervation on kidney function in patients with chronic kidney disease.
    Hering D; Marusic P; Duval J; Sata Y; Head GA; Denton KM; Burrows S; Walton AS; Esler MD; Schlaich MP
    Int J Cardiol; 2017 Apr; 232():93-97. PubMed ID: 28089459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE; Jin Y; Yang WY; Thijs L; Lu YC; Larstorp AC; Persu A; Sapoval M; Rosa J; Widimský P; Jacobs L; Renkin J; Petrák O; Chatellier G; Shimada K; Widimský J; Kario K; Azizi M; Kjeldsen SE; Staessen JA;
    Blood Press; 2015; 24(5):263-74. PubMed ID: 26194721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker.
    Kiuchi MG; Chen S; Hoye NA; Pürerfellner H
    J Interv Card Electrophysiol; 2018 Jan; 51(1):51-59. PubMed ID: 29264729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
    Symplicity HTN-1 Investigators
    Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of renal sympathetic denervation on urinary sodium excretion in patients with resistant hypertension.
    Pöss J; Ewen S; Schmieder RE; Muhler S; Vonend O; Ott C; Linz D; Geisel J; Rump LC; Schlaich M; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Aug; 104(8):672-8. PubMed ID: 25715938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight on Efficacy of Renal Artery Denervation for Refractory Hypertension with Chronic Kidney Diseases: A Long-Term Follow-Up of 24-Hour Ambulatory Blood Pressure.
    Cai H; Fang Z; Lin R; Cai W; Han Y; Su J
    J Interv Cardiol; 2022; 2022():6895993. PubMed ID: 36212674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistant hypertension: is renal denervation the current treatment of choice?
    Reddi AS
    Clin Exp Hypertens; 2014; 36(8):525-30. PubMed ID: 24678737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
    J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
    Gosse P; Cremer A; Pereira H; Bobrie G; Chatellier G; Chamontin B; Courand PY; Delsart P; Denolle T; Dourmap C; Ferrari E; Girerd X; Michel Halimi J; Herpin D; Lantelme P; Monge M; Mounier-Vehier C; Mourad JJ; Ormezzano O; Ribstein J; Rossignol P; Sapoval M; Vaïsse B; Zannad F; Azizi M
    Hypertension; 2017 Mar; 69(3):494-500. PubMed ID: 28115517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.